HALO logo
halo search icon
Ceribell, Inc.

US$18.10

Price Change Indicator
1.14 (6.72%)
Ceribell, Inc.
CBLL · NAS

Ceribell, Inc.

Start Trading CBLL for Free

US$18.10

Price Arrow1.14 (6.72%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusEMA 125 BreakdownHALO All
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Ceribell, Inc. Overview

CBLL Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About CBLL

icon

Website

Ceribell, Inc.

icon

Telephone

1.800.436.0826

icon

Address

360 North Pastoria Avenue, Sunnyvale, CA 94085

Description

Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. Its products include Point-of-Care EEG, which enables early detection and management of suspected seizure patients, promoting precise patient care and hospital-wide efficiencies, Clarity, an AI algorithm that interprets EEG in real-time, providing bedside alerts and continuous monitoring for status epilepticus, and EEG Portal, which makes it easy to remotely review EEG in real-time with pre-annotated EEG insights. The company was founded by Xing Juan Chao, Josef Parvizi, and Chris Chafe on August 29, 2014 and is headquartered in Sunnyvale, CA.

CBLL Price Chart

Key Stats

Market Cap

US$643.51M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 10.85 - 24.33

Trade Value (12mth)

US$1,487,015.00

1 week

4.05%

1 month

-19.01%

YTD

-20.38%

1 year

-3.36%

All time high

32.75

Key Fundamentals

EPS 3 yr Growth

33.80%

EBITDA Margin

-64.10%

Operating Cashflow

-$41m

Free Cash Flow Return

-21.10%

ROIC

-27.50%

Interest Coverage

-30.20

Quick Ratio

9.20

Other Data

Shares Outstanding (Fully Diluted)

38m

HALO Sector

Healthcare

Next Company Report Date

02-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CBLL Announcements

Latest Announcements

DateAnnouncements
12 May 26
12 May 26
12 May 26
12 May 26
08 April 26

CBLL Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.87-1.13-1.46locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.87-1.13-1.46locklocklock
Growth
 %locklocklocklock20.7-30.3-29.5locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Ceribell, Inc. (CBLL:NAS)?
Halo FAQ
The current share price of Ceribell, Inc. (CBLL:NAS) is USD$18.10.
What is the 52-week high share price for Ceribell, Inc. (CBLL:NAS)?
Halo FAQ
The 52-week high share price for Ceribell, Inc. (CBLL:NAS) is USD$24.33.
What is the 52-week low share price for Ceribell, Inc. (CBLL:NAS)?
Halo FAQ
The 52-week low share price for Ceribell, Inc. (CBLL:NAS) is USD$10.85.
What is the dividend yield for Ceribell, Inc. (CBLL:NAS)?
Halo FAQ
Ceribell, Inc. (CBLL:NAS) does not pay a dividend.
What was Ceribell, Inc. (CBLL:NAS) last dividend payment?
Halo FAQ
Ceribell, Inc. (CBLL:NAS) does not pay a dividend.
What is the franking level for Ceribell, Inc. (CBLL:NAS)?
Halo FAQ
Ceribell, Inc. (CBLL:NAS) has a franking level of 0.00%.
In which sector is Ceribell, Inc. (CBLL:NAS) classified?
Halo FAQ
Ceribell, Inc. (CBLL:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial